Seller record · Telehealth service

Aspire Health

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 2 of 8 criteria. S5, analytical documentation: No certificate of analysis or lot document is published on the program pages, the answers or the terms. 1 more criterion also fails; see the table below.

At a glance

Aspire HealthTelehealth service

6/8criteria passed

Price: Compounded semaglutide from $129 a vial, tirzepatide from $149 a vial, plus a monthly care fee
Sells: compounded semaglutide with B3, compounded tirzepatide with B3, Wegovy, and 4 more
FDA letters: None on file

Visit Aspire Health See all eight dispositions

Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.

A Nebraska telehealth practice run by physician assistants and nurse practitioners, selling compounded semaglutide and tirzepatide with B3 by the vial, brand Wegovy and Zepbound, sermorelin and PT-141, and hormone, sexual health and hair loss care. It names three filling pharmacies and prints no street address.

Operating entity Aspire Care LLC

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	Aspire Health's FAQ; Aspire Health's about me page; Aspire Health's weight loss page
S2	Prescription gating	PASS	Aspire Health's weight loss page; Aspire Health's FAQ
S3	Pharmacy identification	PASS	Aspire Health's FAQ
S4	Compounding disclosure	PASS	Aspire Health's weight loss page; Aspire Health's semaglutide for medical weight management page; Aspire Health's FAQ
S5	Analytical documentation	FAIL	Aspire Health's weight loss page; Aspire Health's FAQ
S6	Business address	FAIL	Aspire Health's contact page; Aspire Health's privacy policy; Aspire Health's FAQ
S7	Price disclosure	PASS	Aspire Health's weight loss page; Aspire Health's semaglutide for medical weight management page; Aspire Health's FAQ
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSA board-certified provider reviews each patient's medical history in a telehealth appointment before any prescription, and the about page names the clinical team.Source: Aspire Health's FAQ; Aspire Health's about me page; Aspire Health's weight loss page.

S2PASSThe weight loss page says care begins with a free new-patient consultation, and the answers say medication is billed separately once a provider has prescribed it; no page describes payment before the consultation.Source: Aspire Health's weight loss page; Aspire Health's FAQ.

S3PASSThe answers page names three pharmacies with addresses: Strive Pharmacy in Gilbert, AZ, Boudreaux's New Drug Store in Lake Charles, LA and Rush Pharmacy in Oviedo, FL and Plano, TX.Source: Aspire Health's FAQ.

S4PASSThe weight loss and semaglutide pages state beneath the price tables that compounded medication is not an FDA-approved product, and the answers say compounded medications and peptides have not been approved by the FDA.Source: Aspire Health's weight loss page; Aspire Health's semaglutide for medical weight management page; Aspire Health's FAQ.

S5FAILNo certificate of analysis or lot document is published on the program pages, the answers or the terms.Source: Aspire Health's weight loss page; Aspire Health's FAQ.

S6FAILNo street address appears in the footer, on the contact page, on the about page, in the privacy policy or in the terms; they give only a telephone number and an email address. The terms name Aspire Care LLC and Nebraska law.Source: Aspire Health's contact page; Aspire Health's privacy policy; Aspire Health's FAQ.

S7PASSCompounded semaglutide with B3 from $129 a vial and compounded tirzepatide with B3 from $149 a vial, priced by weekly dose up to $189 and $299. Brand Wegovy at $199 for the two starting doses and $399 for others, and Zepbound at $299, $399 or $449. The weight loss page prints monthly medical care at $49, while the answers page prices the program at $75 a month.Source: Aspire Health's weight loss page; Aspire Health's semaglutide for medical weight management page; Aspire Health's FAQ.

S8PASSNo FDA warning letter names Aspire Health or Aspire Care LLC, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide with B3, compounded tirzepatide with B3, Wegovy, Zepbound, sermorelin, PT-141, hormone replacement therapy.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide Who sells sermorelin Who sells PT-141

Visit Aspire Health

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.